Schedule IV (United States)

GPTKB entity

Predicate	Object
gptkbp:instanceOf	Controlled substance schedule
gptkbp:administeredBy	gptkb:Drug_Enforcement_Administration
gptkbp:controlledBy	gptkb:Federal_government_of_the_United_States
gptkbp:criteria	Low potential for abuse relative to Schedule III Accepted medical use in treatment in the United States Abuse may lead to limited physical or psychological dependence
gptkbp:dateEnacted	1970
gptkbp:example	gptkb:Alprazolam gptkb:Clonazepam gptkb:Diazepam gptkb:Lorazepam gptkb:Phenobarbital gptkb:Tramadol gptkb:Zolpidem gptkb:Propofol gptkb:Butorphanol gptkb:Modafinil gptkb:Pentazocine gptkb:Quazepam gptkb:Suvorexant gptkb:Clorazepate gptkb:Oxazepam gptkb:Carisoprodol gptkb:Eszopiclone gptkb:Chlordiazepoxide gptkb:Midazolam gptkb:Temazepam Diethylpropion Eluxadoline Lorcaserin Mazindol Phentermine Sibutramine Triazolam Difenoxin (with atropine)
gptkbp:governedBy	gptkb:21_U.S.C._§_812
https://www.w3.org/2000/01/rdf-schema#label	Schedule IV (United States)
gptkbp:jurisdiction	gptkb:United_States
gptkbp:legalStatus	Prescription only
gptkbp:partOf	gptkb:Controlled_Substances_Act
gptkbp:regulates	Prescription drugs
gptkbp:relatedTo	gptkb:Schedule_III_(United_States) gptkb:Schedule_II_(United_States) gptkb:Schedule_V_(United_States) gptkb:Schedule_I_(United_States)
gptkbp:bfsParent	gptkb:Schedule_I_(United_States)
gptkbp:bfsLayer	7